1. Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL;
2. Myeloma Research Program, Perlmutter Cancer Center, NYU Langone, New York, NY;
3. Division of Hematology and Blood & Marrow Transplant, University of Kentucky, Lexington, KY;
4. Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT;
5. Division of Hematology, University of Washington, Seattle, WA;
6. Myeloma Program, The University of Chicago Medicine, Chicago, IL;
7. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA;
8. Genentech, Inc, South San Francisco, CA;
9. AbbVie, Inc, North Chicago, IL;
10. Department of Clinical Pharmacy, Ain Shams University, Cairo, Egypt;
11. Division of Hematology, Mayo Clinic, Rochester, MN; and
12. Division of Hematology and Oncology, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA